December 2, 2020
“Cellectar Biosciences (CLRB)… Are other analysts in agreement? They are. 5 Buys and no Holds or Sells have been issued in the last three months. So, the message is clear: CLRB is a Strong Buy. Given the $5.48 average price… Continue Reading…
December 2, 2020
“Cyanotech Corporation (CYAN) Fifteen out of the seventeen one-day moving averages tracked by TradingView.com are pointing to a Strong Buy signal for Cyanotech Corporation (CYAN) at the moment. These include the exponential moving average (5, 10, 20, and 30) and the Hull Moving Average (9).… Continue Reading…
December 1, 2020
If you didn’t catch my post yesterday it can be found here at the link below: REAL TIME UPDATE: ZOMEDICA IS SURGING. 9:44 EST Now that everyone has hopefully read the link I want to get to my main point.… Continue Reading…
November 30, 2020
Zomedica (ZOM) penny stock is surging right now. It was 13 cents before opening this morning. Now it’s 15. If any of you see this in real time I believe if it jumps 3 cents its going to skyrocket. I’ll… Continue Reading…
November 24, 2020
“Cocrystal Pharma (COCP)… Overall, 2 Buys and no Holds or Sells have been assigned in the last three months. Therefore, the analyst consensus is a Moderate Buy. At $4.75, the average price target puts the upside potential at 452%… DiaMedica… Continue Reading…
November 18, 2020
“Onconova Therapeutics, Inc. (NASDAQ:ONTX) Stock Could Reward Investors With a 1053.85% Gain… The consensus price target for the stock as assigned by Wall Street analysts is $1.83, meaning bulls need an upside of 603.85% from its current market value. According… Continue Reading…
November 13, 2020
“Sequans Communications (SQNS)… Sequans holds a unanimous Strong Buy rating from the analyst consensus, based on 4 Buy reviews given in the last two months. Furthermore, the average price target suggests it will more than double, growing by 148% from… Continue Reading…
October 30, 2020
“Lantronix, Inc. (LTRX) Lantronix, Inc. (LTRX) has popped up in this Investopedia column and in my newsletter several times, and just about every time, it has witnessed considerable gains in value. These have been short-lived, however, so you may want to… Continue Reading…
October 20, 2020
“Neos Therapeutics (NEOS)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target… Continue Reading…
Recent Comments